Yongneng Zhang
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 09, 2026
Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension.Yongneng Zhang, Sébastien Bonnet, Steeve Provencher
|Nov 02, 2022
TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure.Maria Areli Lorenzana-Carrillo, Keshav Gopal, Nikole J Byrne
|May 04, 2022
Changing cell fate in the wall of pulmonary arteries.Yongneng Zhang, Evangelos D Michelakis
|Apr 15, 2021
A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!Yongneng Zhang, Evangelos D Michelakis
|Feb 08, 2019
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity.Bruno Saleme, Vikram Gurtu, Yongneng Zhang
Pageof 1
Frequent Collaborators
4 joint publications
Evangelos D Michelakis
3 joint publications
Gopinath Sutendra
2 joint publications
Bruno Saleme
2 joint publications
Alois Haromy
2 joint publications
Michelle Mendiola Pla
1 joint publications
Aristeidis E Boukouris
1 joint publications
Maria Areli Lorenzana-Carrillo
1 joint publications
Saymon Tejay
1 joint publications
Dawn E Bowles
1 joint publications
Sébastien Bonnet
